INTRODUCTION
Although autonomic auras are commonly believed to reflect temporal lobe dysfunction, several reports suggest that orbitofrontal cortex may play a key role in the pathogenesis of autonomic seizures. The clinical manifestations of focal seizures of orbitofrontal origin have not been well defined because of the limited number of seizure-free cases. Although no specific auras or seizures were not found that exclusively characterised the orbitofrontal area as the seizure focus, orbitofrontal seizures usually include psychoaffective phenomena, hallucinations, unpleasant feeling, flashbacks, taste sensations, cephalic sensations, olfactory, light-headedness, body tingling, fuzzy vision et al. Proposed psychic, autonomic and olfactory symptoms are difficult to identify clinically and electrographycally (Smith et al. 2004 , Fisher et al. 2017 ). The déjà vu (DV) phenomenon (French for "already seen") occurs in most healthy individuals, but it can be a sign of temporal lobe epilepsy (TLE), certain psychiatric diseases, and it can be an early symptom of a mass lesion of the brain (Bošnjak Pašić et al. 2018, Vlasov et al. 2013 ), This report presents the clinical, neuroimaging and electroencephalographic findings in a patient with déjà vu phenomenon, who developed autonomic seizures and due to a gangliocytoma involving the orbitofrontal region.
CASE DESCRIPTION
A 69-year-old woman without significant medical history developed autonomic symptoms for three months. The patient complained of chest and abdominal discomfort, epigastric warmth arising into her chest, neck and face, nausea, palpitations, shortness of breath and lightheadedness, fear and stomach butterflies. Epigastric/visceral sensation have had abrupt onset, occured several times per day, lasting 30-60 s and were typical of autonomic type of aura according to the classification of seizure types by the International League Against Epilepsy (ILAE) (Fisher et al. 2017 ). All seizures remained focal, without impaired awareness. Since the 25 years of age, the patient has been experiencing déjà vu (DV) episodes which occured once per week, such as perceiving things as already seen in the same circumstances, lasting up to 10 s. Déjà vu phenomenon decreased with age and has occured once per month, lasting up to 5 s, and were unrelated to autonomic seizures. Déjà vu episodes were usually accompanied by pleasant feelings, and the patient was willing to relive the experience. Neurological examination was normal. Brain magnetic resonance imaging (MR 3.0T) revealed discrete calcified contrast-enhanced cystic lesion localized in the left orbitofrontal area (Fig1 A-D). Normal MR spectra were obtained from the lesion. Routine electroencephalography (Figure 1 , E) showed normal background activity. Theta rhytms and sharp-waves were registered over the left fronto-temporo-basal area. Intermitent tendency of paroxysmal discharges were unaccompanied by clinical manifestations. The patient refused pre-surgical prolonged video-EEG monitoring (VEM). The patient was diagnosed with orbitofrontal epilepsy (classification symptomatic focal autonomic seizures) accompanied with dysmnesic symptoms involving a déjà vu. Treatment with oxycarbamazepine (900 mg per day) was administered, but epileptic seizures were not completely controlled. The patient underwent brain surgery. Post-surgical histological examination indicated gangliocytoma. Following removal of the tumor, the dose of oxycarbamazepine was decreased to 600 mg per day. In the past 18 months, the patient has not experienced autonomic seizures, while déjà vu phenomenon occured on a monthly basis. Danubina, 2018; Vol. 30, No. 2, pp 220-222 impaired awareness (aura) was noted, while absence and automatisms have not been observed. Furthermore, contrasted to all of the reported orbitofrontal seizure cases, epigastric sensations and DV phenomenon were observed in the current patient. This supports hypothesis proposed by Smith which suggest that seizures of orbitofrontal origin without alteration of consciousness probably have more limited spreading of epileptiform activity, as it was found in the presented case with discrete tumorous lesion of the orbitofrontal location. This patient is also unique due to histological characteristic of the structural lesion underlying orbitofrontal seizure. Gangliocytomas usually occured in young patients with a history of drug-resistant epilepsy and have calcified cystic lesion in the temporal lobe or the cerebellum. Close temporal relationship between seizure freedom and surgical resection of the gangliocytoma and the earlier proposed mechanism together with other cases strongly support the hypothesis of orbitofrontal cortex involvement in the patophysiology of simple partial autonomic seizures and did seem to differentiate seizures of orbitofrontal origin from those in anterior cingulate or other areas of the prefrontal cortex. Déjà vu phenomenon in this patient was characterized by a nonspecific pattern of EEG activity, had low frequency and low duration, and occured mostly as an psychological phenomenon, usually induced by fatigue or sleep. However, such nonpathological DV might be associated with altered neuron functioning, probably restricted to a small area within the parahippocampal zone that it does not produce any distinctive EEG pattern (Bošnjak Pašić et 
CONCLUSION
We presented a case of one lesional orbitofrontal epilepsy in whom the disappearance of autonomic seizures after surgical resection limited to the orbitofrontal cortex confirmed the anatomic site of the epileptic focus. Our study also identified probably nonpathological déjà vu phenomenon which is not characteristic of patients with epilepsy and it may be basically a psychological phenomenon.
